The trial met its pre-specified primary endpoint, demonstrating that PDP-716 dosed once daily is equivalent to Alphagan P 0.1% dosed 3 times a day
The tablets will be manufactured and marketed under Vivimed’s brand name “Favulous” across India
This Emergency Use Authorisation will now enable Roche to import the globally manufactured product batches to India
Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution USP, 2% and 0.5% has an estimated market size of US $80 million for twelve months ending December 2020 according to IQVIA
While top industry leaders are optimistic about the growth, they expect the special incentives and regulatory streamlining from the government’s side
With cost optimization leading to cumulative savings of US $80 million over last 8 years, the company now aims to tap bigger opportunities in generics business
Subscribe To Our Newsletter & Stay Updated
